Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Genmab Presents Phase 3 Data from EPCORE FL-1 Trial

    Picture of Genmab A/S logoGenmab A/S
    08/12/2025 07:56
    Dec 8(Reuters) - Genmab A/S GMAB.CO:

SAID ON SUNDAY TRIAL RESULTED IN STATISTICALLY SIGNIFICANT, CLINICALLY MEANINGFUL REDUCTION IN THE RISK OF DISEASE PROGRESSION OR DEATH AND OVERALL RESPONSE COMPARED TO R2 ALONE

 Source text for Workspace: ID:nGNE84hcLD
 Further company coverage: GMAB.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Genmab A/S

    See all news